Abstract
Purpose
Palliative surgery for patients with spinal metastasis provides good clinical outcomes. However, there have been few studies on quality of life (QOL) and cost-utility of this surgery. We aimed to elucidate QOL and cost-utility of surgical treatment for spinal metastasis.
Methods
We prospectively analyzed 47 patients with spinal metastasis from 2010 to 2014 who had a surgical indication. Thirty-one patients who desired surgery underwent spinal surgery (surgery group). Sixteen patients who did not want to undergo spinal surgery (non-surgery group). The EuroQol 5D (EQ-5D) and relevant costs were measured at one, three, six, and 12 months after study enrollment. Health state values were obtained by Japanese EQ-5D scoring and quality-adjusted life years (QALY) gained were calculated for each group. Cost-utility was expressed as the incremental cost-utility ratio (ICUR).
Results
Health state values improved from 0.036 at study enrollment to 0.448 at 12 months in the surgery group, but deteriorated from 0.056 to 0.019 in the non-surgery group, with a significant difference between groups (P < 0.05). The mean QALY gained at 12 months were 0.433 in the surgery group and 0.024 in the non-surgery group. The mean total cost per patient in the surgery group was $25,770 compared with $8615 in the non-surgery group. The ICUR using oneyear follow-up data was $42,003/QALY gained.
Conclusions
Surgical treatment for spinal metastases is associated with significant improvement in health state value. In orthopaedic surgery, an ICUR less than $50,000/QALY gained is considered acceptable cost-effectiveness. Our results indicate that surgical treatment could be cost-effective.
Similar content being viewed by others
References
Stewart BW, Wild CP (2014) World Cancer Report 2014. IARC Press, Lyon
Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12:20–37. doi:10.1634/theoncologist.12-1-20
Sciubba DM, Nguyen T, Gokaslan ZL (2009) Solitary vertebral metastasis. Orthopedic Clin North Am 40:145–154 . doi:10.1016/j.ocl.2008.09.003 viii
Klimo P Jr, Schmidt MH (2004) Surgical management of spinal metastases. Oncologist 9:188–196
Wong DA, Fornasier VL, MacNab I (1990) Spinal metastases: the obvious, the occult, and the impostors. Spine 15:1–4
Weigel B, Maghsudi M, Neumann C, Kretschmer R, Muller FJ, Nerlich M (1999) Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine 24:2240–2246
Helweg-Larsen S, Sorensen PS, Kreiner S (2000) Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 46:1163–1169
Chow E, Bottomley A (2009) Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Exp Rev Pharm Outcomes Res 9:461–465. doi:10.1586/erp.09.50
Kakutani K, Sakai Y, Maeno K, Takada T, Yurube T, Kurakawa T, Miyazaki S, Terashima Y, Ito M, Hara H, Kawamoto T, Ejima Y, Sakashita A, Kiyota N, Kizawa Y, Sasaki R, Akisue T, Minami H, Kuroda R, Kurosaka M, Nishida K (2016) Prospective cohort study of performance status and Activities of daily living after surgery for spinal metastasis. Clin Spine Surg. doi:10.1097/BSD.0000000000000456
Jansson KA, Bauer HC (2006) Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases. Eur Spine J: Off Publ Eur Spine Soc, Eur Spinal Deformity Soc, Eur Sect Cerv Spine Res Soc 15:196–202. doi:10.1007/s00586-004-0870-6
Rompe JD, Hopf CG, Eysel P (1999) Outcome after palliative posterior surgery for metastatic disease of the spine--evaluation of 106 consecutive patients after decompression and stabilisation with the Cotrel-Dubousset instrumentation. Arch Orthop Trauma Surg 119:394–400
Sundaresan N, Rothman A, Manhart K, Kelliher K (2002) Surgery for solitary metastases of the spine: rationale and results of treatment. Spine 27:1802–1806
Hammerberg KW (1992) Surgical treatment of metastatic spine disease. Spine 17:1148–1153
Dobrow MJ, Goel V, Lemieux-Charles L, Black NA (2006) The impact of context on evidence utilization: a framework for expert groups developing health policy recommendations. Soc Sci Med 63:1811–1824. doi:10.1016/j.socscimed.2006.04.020
Dobrow MJ, Goel V, Upshur RE (2004) Evidence-based health policy: context and utilisation. Soc Sci Med 58:207–217
Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K (2005) Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br Vol 87:698–703. doi:10.1302/0301-620X.87B5.15185
Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30:2186–2191
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the eastern cooperative Oncology group. Am J Clin Oncol 5:649–655
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Maryland State Med J 14:61–65
Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, Vernon JD, Walsh JJ (1969) The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 7:179–192. doi:10.1038/sc.1969.30
EuroQol Group (1990) EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 16:199–208
Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, Hamashima C, Hisashige A, Tamura M (2002) Estimating an EQ-5D population value set: the case of Japan. Health Econ 11:341–353. doi:10.1002/hec.673
Brauer CA, Rosen AB, Olchanski NV, Neumann PJ (2005) Cost-utility analyses in orthopaedic surgery. J Bone Joint Surg Am 87:1253–1259. doi:10.2106/JBJS.D.02152
Kuntz KM, Snider RK, Weinstein JN, Pope MH, Katz JN (2000) Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis. Spine 25:1132–1139
Tosteson AN, Lurie JD, Tosteson TD, Skinner JS, Herkowitz H, Albert T, Boden SD, Bridwell K, Longley M, Andersson GB, Blood EA, Grove MR, Weinstein JN, SPORT Investigators (2008) Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years. Ann Intern Med 149:845–853
Rampersaud YR, Tso P, Walker KR, Lewis SJ, Davey JR, Mahomed NN, Coyte PC (2014) Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios. Spine J: Off J North Am Spine Soc 14:244–254. doi:10.1016/j.spinee.2013.11.011
Acknowledgements
The authors thank Dr. S. Akahane and R. Harada, as well as the physical therapists J. Inoue and D. Makiura, for their assistance and helpful criticism.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethics approval
The study protocol was approved by the institutional review board of Kobe University Graduate School of Medicine.
Rights and permissions
About this article
Cite this article
Miyazaki, S., Kakutani, K., Sakai, Y. et al. Quality of life and cost-utility of surgical treatment for patients with spinal metastases: prospective cohort study. International Orthopaedics (SICOT) 41, 1265–1271 (2017). https://doi.org/10.1007/s00264-017-3463-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-017-3463-9